Literature DB >> 23159709

In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.

Ning Qiao1, Ke Wang, Walkiria Schlindwein, Angela Davies, Mingzhong Li.   

Abstract

Cocrystals have shown huge potential to improve the dissolution rate and absorption of a poorly water soluble drug. However, solution mediated phase transformation of cocrystals could greatly reduce the enhancement of its apparent solubility and dissolution rate. The aim of this study is to gain a deep understanding of the phase transition behaviour of cocrystals during dissolution and to investigate the improvement of dissolution rate. Dissolution and transformation behaviour of carbamazepine-nicotinamide (CBZ-NIC) cocrystal, physical mixture and different forms of carbamazepine: form I (CBZ I), form III (CBZ III) and dihydrate (CBZ DH) were studied by different in situ techniques of UV imaging and Raman spectroscopy. It has been found that compared with CBZ III and I, the rate of intrinsic dissolution rate (IDR) of CBZ-NIC cocrystal decreases slowly during dissolution, indicating the rate of crystallisation of CBZ DH from the solution is slow. In situ solid-state characterisation has shown the evolution of conversion of CBZ-NIC cocrystal and polymorphs to its dihydrate form. The study has shown that in situ UV imaging and Raman spectroscopy with a complementary technique of SEM can provide an in depth understanding during dissolution of cocrystals.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159709     DOI: 10.1016/j.ejpb.2012.10.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

Review 1.  Application of UV Imaging in Formulation Development.

Authors:  Yu Sun; Jesper Østergaard
Journal:  Pharm Res       Date:  2016-10-20       Impact factor: 4.200

2.  Attenuated total reflection-Fourier transform infrared spectroscopic imaging of pharmaceuticals in microfluidic devices.

Authors:  Andrew V Ewing; Graham S Clarke; Sergei G Kazarian
Journal:  Biomicrofluidics       Date:  2016-04-20       Impact factor: 2.800

3.  Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.

Authors:  Mingzhong Li; Shi Qiu; Yan Lu; Ke Wang; Xiaojun Lai; Mohammad Rehan
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

4.  Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.

Authors:  Zi Li; Adam J Matzger
Journal:  Mol Pharm       Date:  2016-02-03       Impact factor: 4.939

5.  Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization.

Authors:  Fengjuan Cao; Gordon L Amidon; Nair Rodriguez-Hornedo; Gregory E Amidon
Journal:  Mol Pharm       Date:  2016-02-15       Impact factor: 4.939

6.  Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement.

Authors:  Bhavesh D Kevadiya; Manish Barvaliya; Lu Zhang; Ashish Anovadiya; Harshad Brahmbhatt; Parimal Paul; Chandrabhanu Tripathi
Journal:  Bioengineering (Basel)       Date:  2018-02-13

7.  Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.

Authors:  Chiau Ming Long; Kin Tang; Hitesh Chokshi; Nikoletta Fotaki
Journal:  AAPS PharmSciTech       Date:  2019-02-13       Impact factor: 3.246

8.  Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.

Authors:  Majeed Ullah; Hanif Ullah; Ghulam Murtaza; Qaisar Mahmood; Izhar Hussain
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

9.  Influence of sodium lauryl sulfate and tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour.

Authors:  Mingzhong Li; Ning Qiao; Ke Wang
Journal:  Pharmaceutics       Date:  2013-10-11       Impact factor: 6.321

10.  Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

Authors:  Hao Zhang; Ying Zhu; Ning Qiao; Yang Chen; Linghuan Gao
Journal:  Pharmaceutics       Date:  2017-12-01       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.